

Cover Story
By Matthew Bin Han Ong
In a city that in recent years has come to epitomize the growing racial divide in wealth and health outcomes, Georgetown University’s Lombardi Comprehensive Cancer Center, with help from the Ralph Lauren Corporate Foundation, is establishing a patient navigation, screening, and education center to serve historically marginalized neighborhoods.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- How George Tidmarsh crossed the FDA-industry Rubicon
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval
















